Список литературы использованной при подготовке статей по ЭхоКГ поиску источника эмболии
1. Agmon Y, Khandheria ВК, Meissner I et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942-4.
2. Amarenco P, Cohen A, Tzourio C et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331: 1474-9.
3. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994:89:635-41.
4. Cohen A. Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997;96:3838-41.
5. Cohen A, Tzourio C, Chauvel C et al. Mitral valve strands and the risk of ischemic stroke in elderly patients. The French Study of Aortic Plaques in Stroke (FAPS) Investigators. Stroke 1997;28:1574-8.
6. Daniel WG, Baumgartner H, Gohlke-Barwolf C et al. Leitlinie Klappenvitien im Erwachsenenalter. Clin Res Cardiol 2006;95:62041
7. Daniel WG, Nellessen U, Schroder E et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11:1204-11.
8. Daniel WG. Transcatheter closure of patent foramen ovale. Therapeutic overkill or elegant management for selected patients at risk? Circulation 1992;86:2013-5.
9. Fatkin D, Kuchar DL. Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidenc for «atrial stunning» as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-16.
10. Flachskampf FA, Daniel WG. Closure of patent foramen ovale: is the case really closed as well? Heart 2005;91;449-50.
11. Flachskampf FA, Daniel WG. The role of transesophageal echocardiography in infective endocarditis (editorial). Heart 2000;83:34.
12. Freed LA, Levy D, Levine RA et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
13. Fukuda Y, Makamura K. The incidence of thrombembolism and the hemocoagulative background in patients with rheumatic heart disease. JpnCirc J 1984:48:59.
14. Gilon D, Buonanno FS, Joffe MM et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341:8-13.
15. Grimm RA, Stewart WJ. Maloney JD et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359-66.
17. Hausmann D, Miigge A, Becht 1, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and associaton with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-72.
18. lsada LR, Torelli JN, Stewart WJ, Klein AL. Detection of fibrous strands on prosthetic mitral valves with transesophageal echocardiography: another potential embolic source. J Am Soc Echocardiogr 1994;7:641-5.
19. Kittner SJ, Sharkness CM, Price TR et al. Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: historical features. Neurology 1990;40:281-4.
20. Klein AL, Grimm RA, Black IW et al. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med 1997;126:200-9.
21. Klein AL, Grimm RA, Murray RD et al. Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
22. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-51.
23. Lechat PH, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patiens with stroke. N Engl J Med 1988;318:1148-52.
24. Lethen H, Flachskampf FA, Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997;80:1066-9.
25. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation using transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-5.
26. Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001 ;345:1740-6.
27. Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med 1994;121:41-53.
28. Merino A, Hauptman P, Badimon L et al. Echocardiographic «smoke» is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol 1992;20:1661-8.
29. Miigge A, Daniel WG, Angermann C et al. Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 19:2785— 92.
30. Miigge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989;14:631-8.
31. Miigge A, Kuhn H, Nikutta P, Grote P, Lopez AG, Daniel WG. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994;23:599-607.
32. Pollick C, Taylor C. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 1991;84:223-31.
33. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Arch Intern Med 1994;154:1449-57.
34. Schnittger I. Valvular Strands. In Daniel WG, Kronzon 1, Miigge A (eds.). Cardiogenic Embolism. Baltimore: Williams & Wilkins 1996.
35. Sigel В, Machi J, Beitler JC, Justin JR. Red cell aggregation as a cause of blood-flow echogenicity. Radiology 1983;148:799-802.
36. Stoddard MF, Dawkins PR, Lonaker RA. Mobile strands are frequently attached to the St. Jude Medical mitral valve prosthesis as assessed by two-dimensional transesophageal echocardiography. Am Heart J 1992; 124:671-4.
37. Stone DA, Godard J, Corretti MC et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131:158-61.
38. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;334:1216-21.
39. Webster MWI, Smith HJ, Sharpe DN, Chancellor AM, Swift DL, Bass NM. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-2.
40. Wei K, Wigle DE, Butany J, Rakowski H. Hypertrophic and restrictive cardiomyopathies. In Daniel WG, Kronzon I, Mugge A (eds.). Cardiogenic Embolism. Baltimore: Williams & Wilkins 1996.
41. Windecker S, Wahl A, Chatterjee T et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000:29:101:893-8.
42. Visser CA, Kan G, Meltzer RS et al. Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients. J Am Coll Cardiol 1985;5:1276-80.
